Table 3

Severe toxicities (grades 3 and 4) experienced by patients in cohort 4 (n = 16)

No. of patients with toxicities
Grade 3Grade 4
Hematologic 
    ANC  16 
    WBC 
    Platelets 
    Hemorrhage*  
Cardiac 
    Hypotension  
    Ventricular arrhythmia  
    Cardiac-ischemia/infraction  
Respiratory 
    Hypoxia 
GI/Hepatic 
    Diarrhea 12  
    Abdominal pain/cramping  
    AST or ALT  
    Bilirubin  
Renal   
    Renal failure  
CNS 
    Dysphagia  
    Myalgia  
    Pain  
    Pruritus  
Possible infection 
    Febrile neutropenia  
    Infection w/neutropenia  
Other 
    Fatigue  
    Biochemical tumor lysis  
    Erectile dysfunction  
    Nausea  
No. of patients with toxicities
Grade 3Grade 4
Hematologic 
    ANC  16 
    WBC 
    Platelets 
    Hemorrhage*  
Cardiac 
    Hypotension  
    Ventricular arrhythmia  
    Cardiac-ischemia/infraction  
Respiratory 
    Hypoxia 
GI/Hepatic 
    Diarrhea 12  
    Abdominal pain/cramping  
    AST or ALT  
    Bilirubin  
Renal   
    Renal failure  
CNS 
    Dysphagia  
    Myalgia  
    Pain  
    Pruritus  
Possible infection 
    Febrile neutropenia  
    Infection w/neutropenia  
Other 
    Fatigue  
    Biochemical tumor lysis  
    Erectile dysfunction  
    Nausea  

The table lists the number of patients who experienced severe (grades 3,4) toxicities at any point during their flavopiridol treatment.

*

One patient died from gastrointestinal bleeding.

Excludes transient electrolyte abnormalities.

Close Modal

or Create an Account

Close Modal
Close Modal